Literature DB >> 16393225

High molecular weight adiponectin correlates with insulin sensitivity in patients with hepatitis C genotype 3, but not genotype 1 infection.

Amy Y-H Wang1, Ingrid J Hickman, Ayanthi A Richards, Jonathan P Whitehead, Johannes B Prins, Graeme A Macdonald.   

Abstract

BACKGROUND: Obesity is recognized as a cofactor in hepatitis C (HCV) liver injury. Adipokines may be the link between increasing body mass index (BMI) and disease progression in HCV. Adiponectin is an anti-inflammatory adipokine that is present in serum in a range of multimeric forms that appear to have different metabolic functions.
METHODS: We studied 30 male patients with untreated chronic HCV (15 each with genotypes 1 and 3) and 12 controls. The three groups were matched for age and BMI. Total adiponectin and high (HMW) and low (LMW) molecular weight adiponectin multimers were measured. The relationships between adiponectin, BMI, insulin sensitivity, and liver histology were examined.
RESULTS: Genotype 3 was associated with greater hepatic steatosis and inflammation than genotype 1. Patients with genotype 1 were less insulin sensitive than genotype 3, who had similar insulin sensitivity to controls. Insulin resistance was associated with a decrease in total and HMW adiponectin in both HCV and controls, while LMW adiponectin was unchanged. When the effect of genotype was examined, this association was present with genotype 3 but not genotype 1 infection.
CONCLUSIONS: These data demonstrate that the relationship between insulin resistance and adiponectin is similar in controls and patients with genotype 3 but not genotype 1 infection. The greater degree of insulin resistance in genotype 1 appears to be a genotype-specific effect.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16393225     DOI: 10.1111/j.1572-0241.2005.00311.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  12 in total

Review 1.  Assembly of adiponectin oligomers.

Authors:  Tsu-Shuen Tsao
Journal:  Rev Endocr Metab Disord       Date:  2014-06       Impact factor: 6.514

2.  Immune and Inflammatory Signaling Pathways in Exercise and Obesity.

Authors:  Karsten Krüger; Frank C Mooren; Klaus Eder; Robert Ringseis
Journal:  Am J Lifestyle Med       Date:  2014-10-27

Review 3.  Potential role of leptin, adiponectin and three novel adipokines--visfatin, chemerin and vaspin--in chronic hepatitis.

Authors:  Michał Kukla; Włodzimierz Mazur; Rafał J Bułdak; Krystyna Zwirska-Korczala
Journal:  Mol Med       Date:  2011-07-05       Impact factor: 6.354

Review 4.  Adiponectin receptor signalling in the brain.

Authors:  John Thundyil; Dale Pavlovski; Christopher G Sobey; Thiruma V Arumugam
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

5.  High serum adiponectin correlates with advanced liver disease in patients with chronic hepatitis B virus infection.

Authors:  Chun-Jen Liu; Pei-Jer Chen; Ming-Yang Lai; Chen-Hua Liu; Chi-Lin Chen; Jia-Horng Kao; Ding-Shinn Chen
Journal:  Hepatol Int       Date:  2008-12-02       Impact factor: 6.047

6.  Adiponectin multimers in maternal plasma.

Authors:  S Mazaki-Tovi; R Romero; J P Kusanovic; O Erez; E Vaisbuch; F Gotsch; P Mittal; G N Than; C Nhan-Chang; T Chaiworapongsa; S Edwin; N Camacho; J K Nien; S S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2008-11

7.  Serum level of adiponectin correlated with gender and genotype in patients with chronic hepatitis C.

Authors:  Qing-Hua Meng; Zhong-Hui Duan; Zun-Hui Lin; Hong-Wei Yu; Juan Li; Ya Liu
Journal:  Dig Dis Sci       Date:  2008-09-05       Impact factor: 3.199

Review 8.  Metabolic alterations and hepatitis C: From bench to bedside.

Authors:  Ming-Ling Chang
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

9.  HOMA-AD in Assessing Insulin Resistance in Lean Noncirrhotic HCV Outpatients.

Authors:  Matheus Truccolo Michalczuk; Camila Rippol Kappel; Oscar Birkhan; Ana Carolina Bragança; Mário Reis Alvares-da-Silva
Journal:  Int J Hepatol       Date:  2012-07-16

Review 10.  Adipokines in nonalcoholic steatohepatitis: from pathogenesis to implications in diagnosis and therapy.

Authors:  Emmanuel A Tsochatzis; George V Papatheodoridis; Athanasios J Archimandritis
Journal:  Mediators Inflamm       Date:  2009-06-03       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.